首页> BMJ global health> Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis.

Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kwabena,Asare

第一单位： Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.;Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Faculty of Epidemiology and Population Health, London, UK.

作者： Kwabena,Asare ^[1] ; Lara,Lewis ^[2] ; Johan,van der Molen ^[2] ; Yukteshwar,Sookrajh ^[3] ; Thokozani,Khubone ^[3] ; Thulani,Ngwenya ^[4] ; Ntokozo Siyabonga,Mkhize ^[4] ; Richard John,Lessells ^[5] ; Kogieleum,Naidoo ^[6] ; Phelelani,Sosibo ^[3] ; Christian,Bottomley ^[7] ; Nigel,Garrett ^[8] ; Jienchi,Dorward ^[9]

作者单位： Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.;Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Faculty of Epidemiology and Population Health, London, UK. ^[1] Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa. ^[2] eThekwini Municipality Health Unit, eThekwini Municipality, Durban, KwaZulu-Natal, South Africa. ^[3] Bethesda Hospital, Ubombo, Umkhanyakude District, KwaZulu-Natal, South Africa. ^[4] Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.;KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.;Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa. ^[5] Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.;South African Medical Research Council (SAMRC)-CAPRISA-TB-HIV Pathogenesis and Treatment Research Unit, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa. ^[6] Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. ^[7] Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.;Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa. ^[8] Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa jienchi.dorward@phc.ox.ac.uk.;Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxfordshire, UK. ^[9]

关键词 HIV treatment tuberculosis